CRISPR/Cas9 screens unravel miR-3689a-3p regulating sorafenib resistance in hepatocellular carcinoma via suppressing CCS/SOD1-dependent mitochondrial oxidative stress
Drug Resistance Updates · 2023-11 · 71 · 101015
DOI: 10.1016/j.drup.2023.101015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Resistance Updates, 2023-11. Verfasst von Yuanjun Lu und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Medicine, The University of Hong Kong, Hong Kong S.A.R., P.R. China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, MicroRNAs. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: University Grants Committee Research Grants Council, University Research Committee, University of Hong Kong, The University of Hong Kong.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chinese Medicine, The University of Hong Kong, Hong Kong S.A.R., P.R. China.
- Centre for Chinese Medicine New Drug Development, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong S.A.R., P.R. China.
- Department of Applied Biology and Chemical Technology, Faculty of Science, Hong Kong Polytechnic University, Hong Kong S.A.R., P.R. China.
- School of Chinese Medicine, The University of Hong Kong, Hong Kong S.A.R., P.R. China. Electronic address: ckwang@hku.hk.
Förderung
- University Grants Committee Research Grants Council
- University Research Committee, University of Hong Kong
- The University of Hong Kong
- Health and Medical Research Fund
- Innovation and Technology Fund
Zitieren
APA
Lu, Y., Chan, Y. T., Wu, J., Feng, Z., Yuan, H., Li, Q., Xing, T., Xu, L., Zhang, C., Tan, H. Y., Lee, T. K., Feng, Y., & Wang, N. (2023). CRISPR/Cas9 screens unravel miR-3689a-3p regulating sorafenib resistance in hepatocellular carcinoma via suppressing CCS/SOD1-dependent mitochondrial oxidative stress. Drug Resistance Updates, 71, 101015. https://doi.org/10.1016/j.drup.2023.101015
Vancouver
Lu Y, Chan YT, Wu J, Feng Z, Yuan H, Li Q, et al. CRISPR/Cas9 screens unravel miR-3689a-3p regulating sorafenib resistance in hepatocellular carcinoma via suppressing CCS/SOD1-dependent mitochondrial oxidative stress. Drug Resistance Updates. 2023;71:101015. doi:10.1016/j.drup.2023.101015
BibTeX
@article{Lu2023,
author = {Lu, Yuanjun and Chan, Yau-Tuen and Wu, Junyu and Feng, Zixin and Yuan, Hongchao and Li, Qiucheng and Xing, Tingyuan and Xu, Lin and Zhang, Cheng and Tan, Hor-Yue and Lee, Terence Kin-Wah and Feng, Yibin and Wang, Ning},
title = {CRISPR/Cas9 screens unravel miR-3689a-3p regulating sorafenib resistance in hepatocellular carcinoma via suppressing CCS/SOD1-dependent mitochondrial oxidative stress},
journal = {Drug Resistance Updates},
year = {2023},
volume = {71},
pages = {101015},
doi = {10.1016/j.drup.2023.101015}
}
EUVIMED